Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NOV
NOV logo

NOV Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
19.085
Open
18.700
VWAP
18.95
Vol
230.24K
Mkt Cap
6.69B
Low
18.665
Amount
4.36M
EV/EBITDA(TTM)
7.11
Total Shares
360.40M
EV
7.17B
EV/OCF(TTM)
5.73
P/S(TTM)
0.79
NOV Inc. is an independent provider of equipment and technology to the upstream oil and gas industry. The Company's proprietary technology portfolio supports the industry’s drilling, completion, and production needs. It operates under two segments: Energy Products and Services, and Energy Equipment. The Company’s Energy Products and Services segment primarily designs, manufactures, rents, and sells products and equipment used in drilling, intervention, completion, and production activities. Its products include drill bits, downhole tools, premium drill pipe, drilling fluids, managed pressure drilling, integral and weld-on connectors for conductor strings and surface casing, completion tools, and artificial lift systems. Its Energy Equipment segment manufactures and supports the capital equipment and integrated systems needed for oil and gas exploration and production, both onshore and offshore, as well as for other marine-based, industrial and renewable energy markets.
Show More

Events Timeline

(ET)
2026-03-25
06:40:00
NOV Inc. Invests $200M to Double Capacity at Brazil Facility
select
2026-02-20 (ET)
2026-02-20
06:40:00
NOV Inc. Increases Quarterly Cash Dividend by 20% to 9 Cents per Share
select

News

CNBC
2.0
12:03 PMCNBC
Iran War Triggers Heavy Selling in European Equity Markets
  • Market Sell-Off Pressure: The outbreak of the Iran war has led to significant selling pressure across European equity markets in March, with the UK's FTSE 100 down 5%, while Germany's DAX and France's CAC 40 both fell by 7%, reflecting investor concerns over a second energy price shock in four years.
  • Swiss Market Performance: The Swiss Market Index dropped 7.5% in March, hitting a low of approximately 13% down on March 20 before recovering some losses as the conflict evolved, with analysts suggesting that the Swiss equity market is well-positioned for a potential sentiment rebound.
  • UBS Analyst Insights: UBS analysts highlighted that Swiss equities, trading at around 16x forward earnings with a 3.2% dividend yield, are now more appealing compared to Swiss franc bonds offering zero interest, prompting an upgrade of Swiss equities to
CNBC
8.5
03-27CNBC
Novartis Plans $2 Billion Acquisition of Excellergy for Allergy Treatment
  • Acquisition Strategy: Novartis is planning to acquire U.S.-based biotech Excellergy for up to $2 billion, aiming to enhance its allergy drug portfolio by introducing the early-stage candidate Exl-111, which is expected to outperform existing market treatments in speed and efficacy.
  • Patent Expiration Response: This acquisition represents Novartis' latest bolt-on deal to counteract looming patent expirations, particularly as its best-selling drugs face generic competition, which is anticipated to positively impact future revenue streams.
  • Recent Transaction Activity: Prior to the Excellergy deal, Novartis announced the acquisition of Pikavation Therapeutics for up to $3 billion to secure rights to an experimental breast cancer drug, highlighting its strategic focus on oncology.
  • Market Reaction: While Novartis shares traded sideways in morning trading in Zurich, they have increased by 33% over the past year, reflecting market confidence in its acquisition strategy and future growth potential.
seekingalpha
8.5
03-25seekingalpha
NOV Inc. Invests $200M to Double Subsea Pipe Capacity in Brazil
  • Capacity Expansion Plan: NOV Inc. announced a $200M investment to roughly double the capacity of its subsea flexible pipe manufacturing facility in Açu, Brazil, over the next three years to support anticipated long-term demand growth.
  • Market Demand Forecast: The company indicated that its current manufacturing capacity is operating at or near full utilization, with a backlog extending into 2028, highlighting the potential for increased offshore development activity.
  • Industry Trend Analysis: NOV President and CEO Jose Bayardo emphasized that without the additional capacity planned to come online by late 2029, the industry's current capacity will likely be insufficient to meet demand into the 2030s.
  • Customer Support: An executive from Brazilian customer Petrobras stated that as the world's largest consumer of subsea flexible pipe, they support NOV's investment in Brazil, which enhances local manufacturing capabilities.
CNBC
8.5
03-25CNBC
Merck Acquires Terns Pharmaceuticals for $6.7 Billion
  • Acquisition Scale: Merck announced its acquisition of Terns Pharmaceuticals for $53 per share in cash, totaling approximately $6.7 billion, which represents a 6% premium over Tuesday's closing price, aimed at bolstering its portfolio ahead of Keytruda's patent expiration in 2028.
  • Positive Market Reaction: Following the announcement, Terns' stock rose 5.3% in premarket trading and surged as much as 15% earlier in the day, indicating strong investor enthusiasm for its potential drug and reflecting positive market sentiment regarding the deal.
  • Strategic Importance: This acquisition marks Merck's third multibillion-dollar purchase in the past year, highlighting the company's proactive strategy to expand its oncology investments in anticipation of potential revenue declines following Keytruda's patent expiration.
  • Drug Development Outlook: Terns is developing a drug for a specific type of leukemia, which analysts believe could become a multibillion-dollar competitor, potentially rivaling Novartis' Scemblix, thereby enhancing Merck's position in the biopharmaceutical sector.
Newsfilter
8.5
03-25Newsfilter
NOV to Expand Manufacturing Facility in Brazil
  • Capacity Expansion Plan: NOV plans to invest $200 million over the next three years to nearly double the capacity of its subsea flexible pipe manufacturing facility in Açu, Brazil, to meet anticipated demand from deepwater developments and ensure competitiveness in the 2030s.
  • Demand-Driven Market: The current facility operates at near-full capacity with a backlog extending into 2028, indicating sustained growth in demand for subsea flexible pipes, and NOV's expansion will effectively alleviate future supply-demand imbalances.
  • Introduction of Technological Innovations: This expansion will enable NOV to introduce new technologies, including CO₂-resistant subsea flexible pipes designed for high-CO₂ applications, which is expected to further expand the market and enhance the company's competitiveness in high-end applications.
  • Collaboration with Petrobras: Petrobras supports NOV's investment, believing it will enhance local manufacturing capacity and help achieve offshore production targets, further solidifying NOV's position as a trusted long-term partner.
moomoo
7.0
03-25moomoo
RPT-NOV INC - CAPITAL EXPENDITURE PLAN FOR 2026 TO RISE BY $50 MILLION
  • Capital Expenditure Increase: The capital expenditure plan is set to increase by $50 million.
  • Future Investments: This increase indicates a commitment to future investments and development initiatives.
Wall Street analysts forecast NOV stock price to rise
11 Analyst Rating
Wall Street analysts forecast NOV stock price to rise
5 Buy
5 Hold
1 Sell
Moderate Buy
Current: 0.000
sliders
Low
16.00
Averages
19.18
High
23.00
Current: 0.000
sliders
Low
16.00
Averages
19.18
High
23.00
Goldman Sachs
Ati Modak
Sell
maintain
$17 -> $20
AI Analysis
2026-03-04
Reason
Goldman Sachs
Ati Modak
Price Target
$17 -> $20
AI Analysis
2026-03-04
maintain
Sell
Reason
Goldman Sachs analyst Ati Modak raised the firm's price target on NOV Inc. to $20 from $17 and keeps a Sell rating on the shares. While geopolitical risks could create near-term challenges, there are early signs of dislocations which could present opportunities when compared to fundamentals, the analyst tells investors in a research note. The firm does not expect current geopolitical concerns to meaningfully impact long-term customer plans as significant portions of the activity increases are structural in offsetting decline rates and increasing production capacity, the firm says.
Citi
Neutral
maintain
$17 -> $20
2026-02-11
Reason
Citi
Price Target
$17 -> $20
2026-02-11
maintain
Neutral
Reason
Citi raised the firm's price target on NOV Inc. to $20 from $17 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NOV
Unlock Now

Valuation Metrics

The current forward P/E ratio for Nov Inc (NOV.N) is 15.67, compared to its 5-year average forward P/E of 7.10. For a more detailed relative valuation and DCF analysis to assess Nov Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
7.10
Current PE
15.67
Overvalued PE
66.16
Undervalued PE
-51.96

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
9.94
Current EV/EBITDA
7.48
Overvalued EV/EBITDA
14.23
Undervalued EV/EBITDA
5.65

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.82
Current PS
0.70
Overvalued PS
0.99
Undervalued PS
0.66

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Give me mid and small-cap companies
Intellectia · 130 candidates
Sector: Energy, Energy - Fossil Fuels, Renewable EnergyRegion: USMarket Cap Category: mid, smallList Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
RRC logo
RRC
Range Resources Corp
9.85B
NXE logo
NXE
Nexgen Energy Ltd
8.20B
HESM logo
HESM
Hess Midstream LP
8.07B
FRO logo
FRO
Frontline Plc
7.77B
MUSA logo
MUSA
Murphy USA Inc
7.75B
KNTK logo
KNTK
Kinetik Holdings Inc
7.42B
stocks with increasing insiders buyers
Intellectia · 16 candidates
Market Cap: >= 3.00BDividend Yield Ttm: >= 1.50Insider Transactions: NetPurchaseWeekly Average Turnover: >= 1,000,000Pe Ttm: 10 - 20
Ticker
Name
Market Cap$
top bottom
CI logo
CI
Cigna Group
73.44B
ET logo
ET
Energy Transfer LP
60.60B
F logo
F
Ford Motor Co
54.87B
CINF logo
CINF
Cincinnati Financial Corp
25.24B
BAH logo
BAH
Booz Allen Hamilton Holding Corp
11.59B
WAL logo
WAL
Western Alliance Bancorp
9.99B
low stock prices
Intellectia · 80 candidates
Market Cap: 300.00M - 10.00BPrice: <= $20.00Relative Vol: >= 1.50Beta: LowRisk, ModerateRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
KT logo
KT
KT Corp
9.47B
GGB logo
GGB
Gerdau SA
8.43B
NOV logo
NOV
Nov Inc
6.71B
FNB logo
FNB
FNB Corp
6.36B
CIG logo
CIG
Energy of Minas Gerais Co
5.98B
SRAD logo
SRAD
Sportradar Group AG
5.40B

Whales Holding NOV

A
azValor Asset Management SGIIC, S.A.U.
Holding
NOV
+30.81%
3M Return
H
Heartland Advisors, Inc.
Holding
NOV
+6.96%
3M Return
H
Hotchkis and Wiley Capital Management, LLC
Holding
NOV
+0.05%
3M Return
C
Cobas Asset Management, SGIIC, SA
Holding
NOV
-1.37%
3M Return
G
Greenhaven Associates Inc
Holding
NOV
-6.31%
3M Return
F
First Pacific Advisors, LP
Holding
NOV
-9.19%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Nov Inc (NOV) stock price today?

The current price of NOV is 19.085 USD — it has increased 2.83

What is Nov Inc (NOV)'s business?

NOV Inc. is an independent provider of equipment and technology to the upstream oil and gas industry. The Company's proprietary technology portfolio supports the industry’s drilling, completion, and production needs. It operates under two segments: Energy Products and Services, and Energy Equipment. The Company’s Energy Products and Services segment primarily designs, manufactures, rents, and sells products and equipment used in drilling, intervention, completion, and production activities. Its products include drill bits, downhole tools, premium drill pipe, drilling fluids, managed pressure drilling, integral and weld-on connectors for conductor strings and surface casing, completion tools, and artificial lift systems. Its Energy Equipment segment manufactures and supports the capital equipment and integrated systems needed for oil and gas exploration and production, both onshore and offshore, as well as for other marine-based, industrial and renewable energy markets.

What is the price predicton of NOV Stock?

Wall Street analysts forecast NOV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NOV is19.18 USD with a low forecast of 16.00 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Nov Inc (NOV)'s revenue for the last quarter?

Nov Inc revenue for the last quarter amounts to 2.28B USD, decreased -1.34

What is Nov Inc (NOV)'s earnings per share (EPS) for the last quarter?

Nov Inc. EPS for the last quarter amounts to -0.21 USD, decreased -151.22

How many employees does Nov Inc (NOV). have?

Nov Inc (NOV) has 31605 emplpoyees as of March 31 2026.

What is Nov Inc (NOV) market cap?

Today NOV has the market capitalization of 6.69B USD.